These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 22130826

  • 1. A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome.
    Kruis W, Chrubasik S, Boehm S, Stange C, Schulze J.
    Int J Colorectal Dis; 2012 Apr; 27(4):467-74. PubMed ID: 22130826
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of irritable bowel syndrome with Escherichia coli strain Nissle 1917 (EcN): a retrospective survey].
    Plassmann D, Schulte-Witte H.
    Med Klin (Munich); 2007 Nov 15; 102(11):888-92. PubMed ID: 17992479
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of Probiotic Escherichia coli Nissle 1917 in Patients with Irritable Bowel Syndrome: a Double Blind Placebo-controlled Randomized Trial.
    Faghihi AH, Agah S, Masoudi M, Ghafoori SM, Eshraghi A.
    Acta Med Indones; 2015 Jul 15; 47(3):201-8. PubMed ID: 26586385
    [Abstract] [Full Text] [Related]

  • 4. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
    Kajander K, Myllyluoma E, Rajilić-Stojanović M, Kyrönpalo S, Rasmussen M, Järvenpää S, Zoetendal EG, de Vos WM, Vapaatalo H, Korpela R.
    Aliment Pharmacol Ther; 2008 Jan 01; 27(1):48-57. PubMed ID: 17919270
    [Abstract] [Full Text] [Related]

  • 5. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P.
    Gastroenterol Clin Biol; 2008 Feb 01; 32(2):147-52. PubMed ID: 18387426
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and Safety of New Lactobacilli Probiotics for Unconstipated Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Oh JH, Jang YS, Kang D, Chang DK, Min YW.
    Nutrients; 2019 Nov 27; 11(12):. PubMed ID: 31783597
    [Abstract] [Full Text] [Related]

  • 7. Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial.
    Petersen AM, Mirsepasi H, Halkjær SI, Mortensen EM, Nordgaard-Lassen I, Krogfelt KA.
    J Crohns Colitis; 2014 Nov 27; 8(11):1498-505. PubMed ID: 24972748
    [Abstract] [Full Text] [Related]

  • 8. Combination of a Probiotic and an Antispasmodic Increases Quality of Life and Reduces Symptoms in Patients with Irritable Bowel Syndrome: A Pilot Study.
    Barraza-Ortiz DA, Pérez-López N, Medina-López VM, Minero-Alfaro JI, Zamarripa-Dorsey F, Fernández-Martínez NDC, Llorente-Ramón A, Ramos-Aguilar GA.
    Dig Dis; 2021 Nov 27; 39(3):294-300. PubMed ID: 32810850
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study.
    Dapoigny M, Piche T, Ducrotte P, Lunaud B, Cardot JM, Bernalier-Donadille A.
    World J Gastroenterol; 2012 May 07; 18(17):2067-75. PubMed ID: 22563194
    [Abstract] [Full Text] [Related]

  • 10. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life.
    Lorenzo-Zúñiga V, Llop E, Suárez C, Alvarez B, Abreu L, Espadaler J, Serra J.
    World J Gastroenterol; 2014 Jul 14; 20(26):8709-16. PubMed ID: 25024629
    [Abstract] [Full Text] [Related]

  • 11. Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial.
    Andresen V, Gschossmann J, Layer P.
    Lancet Gastroenterol Hepatol; 2020 Jul 14; 5(7):658-666. PubMed ID: 32277872
    [Abstract] [Full Text] [Related]

  • 12. Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study.
    Sisson G, Ayis S, Sherwood RA, Bjarnason I.
    Aliment Pharmacol Ther; 2014 Jul 14; 40(1):51-62. PubMed ID: 24815298
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic effects, tolerability and safety of a multi-strain probiotic in Iranian adults with irritable bowel syndrome and bloating.
    Jafari E, Vahedi H, Merat S, Momtahen S, Riahi A.
    Arch Iran Med; 2014 Jul 14; 17(7):466-70. PubMed ID: 24979556
    [Abstract] [Full Text] [Related]

  • 14. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.
    Chey WD, Lembo AJ, Lavins BJ, Shiff SJ, Kurtz CB, Currie MG, MacDougall JE, Jia XD, Shao JZ, Fitch DA, Baird MJ, Schneier HA, Johnston JM.
    Am J Gastroenterol; 2012 Nov 14; 107(11):1702-12. PubMed ID: 22986437
    [Abstract] [Full Text] [Related]

  • 15. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG.
    J Clin Gastroenterol; 2012 Mar 14; 46(3):220-7. PubMed ID: 22157240
    [Abstract] [Full Text] [Related]

  • 16. Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN).
    Matthes H, Krummenerl T, Giensch M, Wolff C, Schulze J.
    BMC Complement Altern Med; 2010 Apr 15; 10():13. PubMed ID: 20398311
    [Abstract] [Full Text] [Related]

  • 17. Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients.
    Ludidi S, Jonkers DM, Koning CJ, Kruimel JW, Mulder L, van der Vaart IB, Conchillo JM, Masclee AA.
    Neurogastroenterol Motil; 2014 May 15; 26(5):705-14. PubMed ID: 24588932
    [Abstract] [Full Text] [Related]

  • 18. The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study.
    Skrzydło-Radomańska B, Prozorow-Król B, Cichoż-Lach H, Majsiak E, Bierła JB, Kanarek E, Sowińska A, Cukrowska B.
    Nutrients; 2021 Feb 26; 13(3):. PubMed ID: 33652763
    [Abstract] [Full Text] [Related]

  • 19. Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial.
    Sadrin S, Sennoune SR, Gout B, Marque S, Moreau J, Grillasca J, Pons O, Maixent JM.
    Cell Mol Biol (Noisy-le-grand); 2017 Sep 30; 63(9):122-131. PubMed ID: 28980935
    [Abstract] [Full Text] [Related]

  • 20. A Nonviable Probiotic in Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study.
    Mack I, Schwille-Kiuntke J, Mazurak N, Niesler B, Zimmermann K, Mönnikes H, Enck P.
    Clin Gastroenterol Hepatol; 2022 May 30; 20(5):1039-1047.e9. PubMed ID: 34214682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.